Clinical Trials Browser

Phase 2 × Idarubicin × Plasma cell × Clear all

NCT00124813 2010-02-02

Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma

Phase 2 Unknown

Multiple Myeloma